• Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

    28 days ago - By ScienceDaily

    A new study highlights how a clinically approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies. The research focuses on a protein called TRIB2, which is linked to promoting survival and drug resistance in solid tumors and blood cancers and is therefore of particular interest as a therapeutic target.
    Read more ...

     

  • New drug supercharges pancreatic cancer treatments and may boost survival rates by 50%

    New drug supercharges pancreatic cancer treatments and may boost survival rates by 50%

    28 days ago - By Daily Mail

    Pancreatic cancer is so deadly because its location makes it difficult to catch early and because it becomes chemo resistant. But a new drug developed by Cedars-Sinai Medical center may change that.
    Read more ...